{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-24T04:48:12.829505+00:00","published_at":"2026-10-24T04:48:12.829505+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:20","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:21","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:22","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:23","stance":"supports"}],"claim_ids":["alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:legal_name:1","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:entity_status:3","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:published_fact:4","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:20","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:21","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:22","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:23"]},{"evidence_id":"alpha:projection-evidence:document:122edb2683a961e7bb4b9355c2e0cef0a1f73d61080460852d8f6dd3a122642c","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","title":"BriaCell Therapeutics Corp. DEF 14A 2026-02-12","identifier":null,"locator":null,"source_date":"2026-02-12","retrieved_at":"2026-04-25T00:31:02.342+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:5","stance":"supports"}],"claim_ids":["alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:5"]},{"evidence_id":"alpha:projection-evidence:document:f0f54f2047e2fb704c660bbcd358a1d2a4a4dd7ca3d16c0423abd577a9d4540f","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","title":"BCTXZ 10-K executive officers","identifier":null,"locator":null,"source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:6","stance":"supports"}],"claim_ids":["alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:6"]},{"evidence_id":"alpha:projection-evidence:document:27429acc03a62e58fb0c7fe26f9722737eeda1cf0b1c8a0060f7b2e2c52e788a","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","title":"BCTXL 10-K executive officers","identifier":null,"locator":null,"source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:7","stance":"supports"}],"claim_ids":["alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:7"]},{"evidence_id":"alpha:projection-evidence:document:66139f3670f4d313f95ce0b550a5f0292cb3513e7f9646bd25026e7b30d026da","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","title":"BCTXZ 10-K executive officers","identifier":null,"locator":null,"source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:8","stance":"supports"}],"claim_ids":["alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:8"]},{"evidence_id":"alpha:projection-evidence:document:6104398cd9020884a8ebe06c772e263ecf65b20ac68eb973c945c032c95009d5","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","title":"BCTXL 10-K executive officers","identifier":null,"locator":null,"source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:9","stance":"supports"}],"claim_ids":["alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:9"]},{"evidence_id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","aliases":[],"source_type":"board_seats","source_family":"sec","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","title":"Audit","identifier":null,"locator":null,"source_date":null,"retrieved_at":null,"content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:10","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:11","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:12","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:13","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:14","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:15","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:16","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:17","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:18","stance":"supports"},{"claim_id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:19","stance":"supports"}],"claim_ids":["alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:10","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:11","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:12","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:13","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:14","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:15","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:16","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:17","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:18","alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:19"]}]},"claims":[{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:legal_name:1","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BriaCell Therapeutics Corp.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"BriaCell Therapeutics Corp.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:entity_status:3","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:published_fact:4","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:5","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mr-martin-schmieg","object_label":"Martin E. Schmieg","object_source_name_forms":[],"value":"Martin E. Schmieg: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mr-martin-schmieg","name":"Martin E. Schmieg"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:document:122edb2683a961e7bb4b9355c2e0cef0a1f73d61080460852d8f6dd3a122642c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BriaCell Therapeutics Corp. DEF 14A 2026-02-12","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":"2026-02-12","retrieved_at":"2026-04-25T00:31:02.342+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-12","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:6","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:grant-e-pickering-m-b-a","object_label":"Gadi Levin, CA, MBA","object_source_name_forms":[],"value":"Gadi Levin, CA, MBA: Chief Financial Officer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:grant-e-pickering-m-b-a","name":"Gadi Levin, CA, MBA"},"title":"Chief Financial Officer and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-16","valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:document:f0f54f2047e2fb704c660bbcd358a1d2a4a4dd7ca3d16c0423abd577a9d4540f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-16T00:00:00+00:00","effective_from":"2025-10-16","effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:7","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:giuseppe-del-priore-md-mph","object_label":"Giuseppe Del Priore, MD, MPH","object_source_name_forms":[],"value":"Giuseppe Del Priore, MD, MPH: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:giuseppe-del-priore-md-mph","name":"Giuseppe Del Priore, MD, MPH"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-16","valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:document:27429acc03a62e58fb0c7fe26f9722737eeda1cf0b1c8a0060f7b2e2c52e788a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXL 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-16T00:00:00+00:00","effective_from":"2025-10-16","effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:8","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:miguel-a-lopez-lago-phd","object_label":"Miguel A. Lopez-Lago, PhD","object_source_name_forms":[],"value":"Miguel A. Lopez-Lago, PhD: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:miguel-a-lopez-lago-phd","name":"Miguel A. Lopez-Lago, PhD"},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-16","valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:document:66139f3670f4d313f95ce0b550a5f0292cb3513e7f9646bd25026e7b30d026da","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-16T00:00:00+00:00","effective_from":"2025-10-16","effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:9","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:william-v-williams-md-frcp","object_label":"William V. Williams, MD, FRCP","object_source_name_forms":[],"value":"William V. Williams, MD, FRCP: President, Chief Executive Officer, and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:william-v-williams-md-frcp","name":"William V. Williams, MD, FRCP"},"title":"President, Chief Executive Officer, and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-16","valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:document:6104398cd9020884a8ebe06c772e263ecf65b20ac68eb973c945c032c95009d5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXL 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-16T00:00:00+00:00","effective_from":"2025-10-16","effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:10","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Dr. Vaughn C. Embro-Pantalony; Members Dr. Vaughn C. Embro-Pantalony (Chair); Dr. Jane Gross; Martin E. Schmieg","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Dr. Vaughn C. Embro-Pantalony","members":[{"display_name":"Dr. Vaughn C. Embro-Pantalony","person_slug":"dr-vaughn-c-embro-pantalony","is_chair":true},{"display_name":"Dr. Jane Gross","person_slug":"dr-jane-gross","is_chair":false},{"display_name":"Martin E. Schmieg","person_slug":"mr-martin-schmieg","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:11","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:dr-vaughn-c-embro-pantalony","object_label":"Dr. Vaughn C. Embro-Pantalony","object_source_name_forms":[],"value":"Dr. Vaughn C. Embro-Pantalony: chair, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:dr-vaughn-c-embro-pantalony","name":"Dr. Vaughn C. Embro-Pantalony"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:12","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:dr-jane-gross","object_label":"Dr. Jane Gross","object_source_name_forms":[],"value":"Dr. Jane Gross: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:dr-jane-gross","name":"Dr. Jane Gross"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:13","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:mr-martin-schmieg","object_label":"Martin E. Schmieg","object_source_name_forms":[],"value":"Martin E. Schmieg: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mr-martin-schmieg","name":"Martin E. Schmieg"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:14","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Martin E. Schmieg; Members Martin E. Schmieg (Chair); Dr. Vaughn C. Embro-Pantalony","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Martin E. Schmieg","members":[{"display_name":"Martin E. Schmieg","person_slug":"mr-martin-schmieg","is_chair":true},{"display_name":"Dr. Vaughn C. Embro-Pantalony","person_slug":"dr-vaughn-c-embro-pantalony","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:15","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:mr-martin-schmieg","object_label":"Martin E. Schmieg","object_source_name_forms":[],"value":"Martin E. Schmieg: chair, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:mr-martin-schmieg","name":"Martin E. Schmieg"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:16","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:dr-vaughn-c-embro-pantalony","object_label":"Dr. Vaughn C. Embro-Pantalony","object_source_name_forms":[],"value":"Dr. Vaughn C. Embro-Pantalony: member, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:dr-vaughn-c-embro-pantalony","name":"Dr. Vaughn C. Embro-Pantalony"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:17","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Mr. Jamieson Bondarenko; Members Mr. Jamieson Bondarenko (Chair); Dr. Rebecca Taub","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Mr. Jamieson Bondarenko","members":[{"display_name":"Mr. Jamieson Bondarenko","person_slug":"mr-jamieson-bondarenko","is_chair":true},{"display_name":"Dr. Rebecca Taub","person_slug":"dr-rebecca-taub","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:18","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:mr-jamieson-bondarenko","object_label":"Mr. Jamieson Bondarenko","object_source_name_forms":[],"value":"Mr. Jamieson Bondarenko: chair, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:mr-jamieson-bondarenko","name":"Mr. Jamieson Bondarenko"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:19","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:dr-rebecca-taub","object_label":"Dr. Rebecca Taub","object_source_name_forms":[],"value":"Dr. Rebecca Taub: member, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:dr-rebecca-taub","name":"Dr. Rebecca Taub"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:20","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BCTX (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"BCTX","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:21","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BCTXL (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"BCTXL","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:22","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BCTXZ (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"BCTXZ","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:23","subject_id":"alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BCT (TSX)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"BCT","exchange":"TSX","exchange_display":"TSX","mic":"XTSE","currency":"CAD","security_type":"equity","listing_status":"active","is_primary":false},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:12.829505+00:00","sources":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp","source_date":null,"retrieved_at":"2026-10-24T04:48:12.829505+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:122edb2683a961e7bb4b9355c2e0cef0a1f73d61080460852d8f6dd3a122642c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BriaCell Therapeutics Corp. DEF 14A 2026-02-12","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":"2026-02-12","retrieved_at":"2026-04-25T00:31:02.342+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f0f54f2047e2fb704c660bbcd358a1d2a4a4dd7ca3d16c0423abd577a9d4540f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:27429acc03a62e58fb0c7fe26f9722737eeda1cf0b1c8a0060f7b2e2c52e788a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXL 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:66139f3670f4d313f95ce0b550a5f0292cb3513e7f9646bd25026e7b30d026da","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:6104398cd9020884a8ebe06c772e263ecf65b20ac68eb973c945c032c95009d5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCTXL 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm","source_date":"2025-10-16T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:10.656486+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.815,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.793,"cross_source_agreement":0.75,"temporal_completeness":0.417},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":5,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-24T04:48:12.829505+00:00","observed_at":"2026-10-24T04:48:12.829505+00:00","reviewed_at":"2026-10-24T04:48:12.829505+00:00","verified_at":"2026-10-24T04:48:12.829505+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/briacell-therapeutics-corp/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}